"This repeatedly strong result illustrates once again that we are on track with the transformation of our company. We are already stronger today and more profitable than when we started the change process a few years ago,“ said Karl-Ludwig Kley, Chairman of the Executive Board of Merck KGaA, Darmstadt, Germany. In the third quarter 2013 our company continued his solid business performance in a challenging market environment.
The pharmaceutical, chemical and life science company posted solid organic revenue growth of 4.7%. EBITDA pre one-time items increased significantly by 10% in spite of headwinds from foreign exchange effects so that the guidance could be increased to a range between about € 3.2 billion and € 3.25 billion.
On this site we have bundled all information as well as relevant links regarding our third-quarter 2013 earnings. In addition to the online report, you will find the press release, analyst presentation and pictures.